COVID-19 cardiac injury: Implications for long-term surveillance and outcomes in survivors
暂无分享,去创建一个
[1] W. Paulus,et al. Ventricular myocarditis coincides with atrial myocarditis in patients. , 2014, Cardiovascular pathology : the official journal of the Society for Cardiovascular Pathology.
[2] D. Morrow,et al. COVID-19 for the Cardiologist , 2020, JACC: Basic to Translational Science.
[3] E. Marbán,et al. COVID-19 and the Heart , 2020, Circulation research.
[4] Roberto Maroldi,et al. Cardiac Involvement in a Patient With Coronavirus Disease 2019 (COVID-19). , 2020, JAMA cardiology.
[5] T. West,et al. Covid-19 in Critically Ill Patients in the Seattle Region — Case Series , 2020, The New England journal of medicine.
[6] Hongliang Li,et al. The Science Underlying COVID-19: Implications for the Cardiovascular System. , 2020, Circulation.
[7] Ke Ma,et al. Clinical characteristics of 113 deceased patients with coronavirus disease 2019: retrospective study , 2020, BMJ.
[8] R. D. de Boer,et al. From Inflammation to Fibrosis—Molecular and Cellular Mechanisms of Myocardial Tissue Remodelling and Perspectives on Differential Treatment Opportunities , 2017, Current Heart Failure Reports.
[9] Eun Ji Kim,et al. Presenting Characteristics, Comorbidities, and Outcomes Among 5700 Patients Hospitalized With COVID-19 in the New York City Area. , 2020, JAMA.
[10] Ting-hui Chen,et al. Predictors of long-term outcome in patients with biopsy proven inflammatory cardiomyopathy , 2018, Journal of geriatric cardiology : JGC.
[11] D. Newby,et al. Long-Term Outcomes in Patients With Type 2 Myocardial Infarction and Myocardial Injury , 2017, Circulation.
[12] J. Penninger,et al. SARS‐coronavirus modulation of myocardial ACE2 expression and inflammation in patients with SARS , 2009, European journal of clinical investigation.
[13] Sunil V. Rao,et al. Management of Acute Myocardial Infarction During the COVID-19 Pandemic , 2020, Journal of the American College of Cardiology.
[14] Nathaniel Hupert,et al. Clinical Characteristics of Covid-19 in New York City , 2020, The New England journal of medicine.
[15] Yi Feng,et al. The ACE2 expression in human heart indicates new potential mechanism of heart injury among patients infected with SARS-CoV-2 , 2020, Cardiovascular research.
[16] L. Rosella,et al. Acute Myocardial Infarction after Laboratory‐Confirmed Influenza Infection , 2018, The New England journal of medicine.
[17] E. Kogan,et al. Myocardial Biopsy In "Idiopathic» Atrial Fibrillation And Other Arrhythmias: Nosological Diagnosis, Clinical And Morphological Parallels, And Treatment. , 2016, Journal of atrial fibrillation.
[18] T. Chao,et al. The association between influenza infection, vaccination, and atrial fibrillation: A nationwide case-control study. , 2016, Heart rhythm.
[19] O. Morel,et al. Ventricular arrhythmias and sudden cardiac arrest in Takotsubo cardiomyopathy: Incidence, predictive factors, and clinical implications. , 2018, Heart rhythm.
[20] H. Figulla,et al. Successful use of a wearable cardioverter-defibrillator in myocarditis with normal ejection fraction , 2010, Clinical Research in Cardiology.
[21] G. Fonarow,et al. Association of Coronavirus Disease 2019 (COVID-19) With Myocardial Injury and Mortality. , 2020, JAMA cardiology.
[22] Erwan L'Her,et al. Compassionate Use of Remdesivir for Patients with Severe Covid-19 , 2020, The New England journal of medicine.
[23] J. Olgin,et al. Prospective Countywide Surveillance and Autopsy Characterization of Sudden Cardiac Death: POST SCD Study , 2018, Circulation.
[24] A. Kadish,et al. Impact of Nontraditional Antiarrhythmic Drugs on Sudden Cardiac Death , 2004 .
[25] J. Goldberger,et al. 114 – Impact of Nontraditional Antiarrhythmic Drugs on Sudden Cardiac Death , 2018 .
[26] E. Arbustini,et al. Myocardial localization of coronavirus in COVID‐19 cardiogenic shock , 2020, European journal of heart failure.
[27] C. Sardu. “ Persistent Long-Term Structural , Functional , and Metabolic Changes After Stress-Induced ( Takotsubo ) Cardiomyopathy ” Circulation , 2018 .
[28] J. Xiang,et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study , 2020, The Lancet.
[29] R. Shephard. Sudden Deaths in Young Competitive Athletes: Analysis of 1866 Deaths in the United States, 1980–2006 , 2010 .
[30] A. Henning,et al. Persistent Long-Term Structural, Functional, and Metabolic Changes After Stress-Induced (Takotsubo) Cardiomyopathy , 2017, Circulation.
[31] Xi Chen,et al. Epicardial adipose tissue density and volume are related to subclinical atherosclerosis, inflammation and major adverse cardiac events in asymptomatic subjects. , 2017, Journal of cardiovascular computed tomography.
[32] M. Boutjdir,et al. Autoimmune and inflammatory K+ channelopathies in cardiac arrhythmias: Clinical evidence and molecular mechanisms. , 2019, Heart rhythm.
[33] H. Huikuri,et al. Temporal Trends in the Clinical and Pathological Characteristics of Victims of Sudden Cardiac Death in the Absence of Previously Identified Heart Disease , 2016, Circulation. Arrhythmia and electrophysiology.
[34] E. Romano. Association of Cardiac Injury with Mortality in Hospitalized Patients with COVID-19. , 2021, Arquivos brasileiros de cardiologia.
[35] Qiurong Ruan,et al. Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China , 2020, Intensive Care Medicine.
[36] Xiang Xie,et al. COVID-19 and the cardiovascular system , 2020, Nature Reviews Cardiology.
[37] W. Gong,et al. Association of Cardiac Injury With Mortality in Hospitalized Patients With COVID-19 in Wuhan, China. , 2020, JAMA cardiology.
[38] G. Barbati,et al. Long-Term Evolution and Prognostic Stratification of Biopsy-Proven Active Myocarditis , 2013, Circulation.
[39] Shao‐Wei Chen,et al. Heart Failure and Mortality of Adult Survivors from Acute Myocarditis Requiring Intensive Care Treatment - A Nationwide Cohort Study , 2017, International journal of medical sciences.
[40] T. Strabelli,et al. COVID-19 and the Heart. , 2020, Arquivos brasileiros de cardiologia.
[41] S. Rizzo,et al. Ventricular Arrhythmias in Myocarditis: Characterization and Relationships With Myocardial Inflammation. , 2020, Journal of the American College of Cardiology.
[42] G. Heusch,et al. Coronary microembolization and microvascular dysfunction. , 2018, International journal of cardiology.
[43] N. M. Hettiarachchi,et al. Clinical Characteristics of COVID-19 , 2020, Journal of the Ceylon College of Physicians.
[44] Binita Shah,et al. ST-Segment Elevation in Patients with Covid-19 — A Case Series , 2020, The New England journal of medicine.
[45] B. Maron,et al. Sudden Deaths in Young Competitive Athletes: Analysis of 1866 Deaths in the United States, 1980–2006 , 2009, Circulation.
[46] A. Malavazos,et al. Targeting the Adipose Tissue in COVID‐19 , 2020, Obesity.
[47] L. Cooper,et al. Recognizing COVID-19–related myocarditis: The possible pathophysiology and proposed guideline for diagnosis and management , 2020, Heart Rhythm.
[48] J. Magnani,et al. Survival in biopsy-proven myocarditis: a long-term retrospective analysis of the histopathologic, clinical, and hemodynamic predictors. , 2006, American heart journal.
[49] Y. Hu,et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China , 2020, The Lancet.
[50] M. Packer. Epicardial Adipose Tissue May Mediate Deleterious Effects of Obesity and Inflammation on the Myocardium. , 2018, Journal of the American College of Cardiology.
[51] Tao Guo,et al. Cardiovascular Implications of Fatal Outcomes of Patients With Coronavirus Disease 2019 (COVID-19) , 2020, JAMA cardiology.